Corrigendum to biocompatible bacteria-derived vesicles show inherent antimicrobial activity [Journal of controlled release, volume 290, page 46-55 (2018), page 46-55]

Eilien Schulz; Adriely Goes; Ronald Garcia; Fabian Panter; Marcus Koch; Rolf Müller; Kathrin Fuhrmann; Gregor Fuhrmann

doi:10.1016/j.jconrel.2018.11.027

Corrigendum to biocompatible bacteria-derived vesicles show inherent antimicrobial activity [Journal of controlled release, volume 290, page 46-55 (2018), page 46-55]

J Control Release. 2019 Jan 10:293:155-157. doi: 10.1016/j.jconrel.2018.11.027. Epub 2018 Dec 5.

Authors

Eilien Schulz¹, Adriely Goes¹, Ronald Garcia², Fabian Panter³, Marcus Koch⁴, Rolf Müller⁵, Kathrin Fuhrmann⁶, Gregor Fuhrmann⁷

Affiliations

¹ Helmholtz Centre for Infection Research (HZI), Biogenic Nanotherapeutics Group (BION), Helmholtz Institute for Pharmaceutical Research Saarland (HIPS), Campus E8.1, Saarbrücken 66123, Germany; Department of Pharmacy, Saarland University, Campus E8.1, Saarbrücken 66123, Germany.
² Helmholtz Centre for Infection Research (HZI), Department of Microbial Natural Products (MINS), Helmholtz Institute for Pharmaceutical Research Saarland (HIPS), Campus E8.1, Saarbrücken 66123, Germany; German Center for Infection Research (DZIF), Braunschweig 38124, Germany.
³ Helmholtz Centre for Infection Research (HZI), Department of Microbial Natural Products (MINS), Helmholtz Institute for Pharmaceutical Research Saarland (HIPS), Campus E8.1, Saarbrücken 66123, Germany.
⁴ INM - Leibniz Institute for New Materials, Campus D2 2, Saarbrücken 66123, Germany.
⁵ Department of Pharmacy, Saarland University, Campus E8.1, Saarbrücken 66123, Germany; Helmholtz Centre for Infection Research (HZI), Department of Microbial Natural Products (MINS), Helmholtz Institute for Pharmaceutical Research Saarland (HIPS), Campus E8.1, Saarbrücken 66123, Germany; German Center for Infection Research (DZIF), Braunschweig 38124, Germany.
⁶ Helmholtz Centre for Infection Research (HZI), Biogenic Nanotherapeutics Group (BION), Helmholtz Institute for Pharmaceutical Research Saarland (HIPS), Campus E8.1, Saarbrücken 66123, Germany.
⁷ Helmholtz Centre for Infection Research (HZI), Biogenic Nanotherapeutics Group (BION), Helmholtz Institute for Pharmaceutical Research Saarland (HIPS), Campus E8.1, Saarbrücken 66123, Germany; Department of Pharmacy, Saarland University, Campus E8.1, Saarbrücken 66123, Germany. Electronic address: gregor.fuhrmann@helmholtz-hips.de.

PMID: 30529880
DOI: 10.1016/j.jconrel.2018.11.027

No abstract available

Publication types

Published Erratum